New York GU Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies | Conference

PSMA-Targeted 177Lu-PSMA-617 Heads for Regulatory Approval in mCRPC
April 22, 2021

Scott T. Tagawa, MD, considers data for the novel PSMA-targeted radiopharmaceutical 177Lu-PSMA-617.

Expert Explores the Current Status of Radium-223 Use in Castration-Resistant Prostate Cancer
March 28, 2021

During a presentation at the 14th Annual New York GU Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Scott T. Tagawa, MD, reviewed important findings related to radium-223 and its use in patients with castration-resistant prostate cancer.

How To Implement Next-Generation Imaging Recommendations in Prostate Cancer Management
March 26, 2021

At the New York GU 14th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Phillip J. Koo, MD, discussed the recommendations issued for the early detection of metastatic prostate cancer using next-generation imaging.